Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis

BACKGROUND: Blood loss and deep vein thrombosis (DVT) are important complications after total knee arthroplasty (TKA). Topical tranexamic acid (TXA) effectively reduces wound bleeding but may elevate the risk of DVT. In contrast, rivaroxaban potently prevents DVT but has been associated with bleedin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong Tae, Kang, Min Wook, Lee, Joon Kyu, Lee, Young Min, Kim, Joong Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052595/
https://www.ncbi.nlm.nih.gov/pubmed/30021575
http://dx.doi.org/10.1186/s12891-018-2151-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052595/
https://www.ncbi.nlm.nih.gov/pubmed/30021575
http://dx.doi.org/10.1186/s12891-018-2151-2

Ejemplares similares